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Feline coronaviruses (FCoVs) are found throughout the world. Infection with FCoV can result in a diverse range of signs from
clinically inapparent infections to a highly fatal disease called feline infectious peritonitis (FIP). FIP is one of the most serious
viral diseases of cats. While there is neither an eﬀective vaccine, nor a curative treatment for FIP, a diagnostic protocol for FCoV
would greatly assist in the management and control of the virus. Clinical ﬁndings in FIP are non-speciﬁc and not helpful in
making a diﬀerential diagnosis. Haematological and biochemical abnormalities in FIP cases are also non-speciﬁc. The currently
available serological tests have low speciﬁcity and sensitivity for detection of active infection and cross-react with FCoV strains
of low pathogenicity, the feline enteric coronaviruses (FECV). Reverse transcriptase polymerase chain reaction (RT-PCR) has
been used to detect FCoV and is rapid and sensitive, but results must be interpreted in the context of clinical ﬁndings. At present, a
deﬁnitivediagnosisofFIPcanbeestablishedonlybyhistopathologicalexaminationofbiopsies.Thispaperdescribesandcompares
diagnostic methods for FCoVs and includes a brief account of the virus biology, epidemiology, and pathogenesis.
1.Introduction
Feline coronaviruses (FCoVs) are enveloped viruses with
a large, capped, polyadenylated RNA genome of about
29,190 nucleotides. The FCoVs are group 1 coronaviruses,
recently designated as members of subgroup 1a in the
family Coronaviridae. Other members of this subgroup
include transmissible gastroenteritis virus (TGEV), canine
coronavirus (CCV), raccoon dog coronavirus (RDCoV), and
Chinese ferret badger coronavirus (CFBCoV) [1].
The order of the genes encoding the viral polymerase
(Pol) and the four structural proteins (the spike, envelope,
membrane, and nucleocapsid proteins) is 5
-Pol-S-E-M-N-
3
. These genes are present in all coronaviruses. The feline
coronavirus genome also includes additional genes (3a, 3b,
3c, 7a, and 7b) that encode nonstructural proteins. The
functionsofthesegeneproductsarenotfullyunderstood[2].
Two biological types of FCoVs are known: feline infec-
tious peritonitis virus (FIPV) and feline enteric coronavirus
(FECV). In the widely accepted “in vivo mutation” theory,
FIPV arises by mutation from parental FECV in the gas-
trointestinal tract of an infected cat, spreads systemically
and causes FIP [3–5]. The mutation sites are not fully
understood, but some accessory genes (3c and 7b) are
candidates for the site of the critical mutations responsible
for FIP [6, 7]. An alternative hypothesis is the “circulating
virulent/avirulent” theory, which suggests that both virulent
and avirulent strains circulate in cat populations, and sus-
ceptible individuals exposed to the virulent strains develop
the disease. This hypothesis was proposed after sequence
analysis of four genes (Pol, S, M and 7b) from FCoV-infected
healthy cats and cats with FIP. Phylogenetic analyses revealed
that sequences of the M and 7b genes in viruses obtained
fromhealthycatsweredistinctfromthoseobtainedfromsick
cats and suggest the coexistence of both biotypes in cats [8].
However, as these viruses undergo mutation readily [7]a n d
genetic diﬀerences in the 7b gene were not correlated with
pathogenicityinanotherstudy[9],theepidemiologyofFIPV
is yet to be clariﬁed.
Regardless of the source of FIPV and uncertainty about
the signiﬁcance of genetic diﬀerences, the relationship
between virulence and macrophage/monocyte tropism has
been ﬁrmly established [7]. While both FIPV and FECV may
causeviraemia[10–12],onlyFIPVreplicatesinmacrophages2 Veterinary Medicine International
and causes the disease [5, 13]. Complex immune reactions
between the virus, antiviral antibodies, and complement
cause disseminated vasculitis, which is the hallmark of FIP
[14, 15].
Based on their antigenic relationship with canine coro-
navirus, sequence analyses of the S gene, and their growth
characteristics in vitro, FCoV strains can be classiﬁed into
serotypes I and II. FCoV serotype I strains are wholly feline.
They are diﬃcult to grow in cell culture and cause a slowly
developing cytopathic eﬀect. FCoV serotype II strains seem
to have arisen by recombination between FCoV serotype I
and CCV. They grow more rapidly than serotype I viruses
and induce a lytic cytopathic eﬀect. FIPV and FECV strains
can be serotype I or II [6, 16–18].
FCoV infection is extremely common in cat populations.
Antibodies against FCoV are found in 20%–60% of pet
cats and up to 100% of cats in catteries or multi-cat
households [14, 19–24]. FCoVs are highly infectious and
spread predominantly by the faecal-oral route. About 75%–
100% of cats in multi-cat environments shed the virus [14,
25, 26].
2.DiagnosisofFCoV
FECV infections are usually associated with mild disease
at most. Many cases remain asymptomatic, and in young
kittens mild transient diarrhoea of several days duration
is generally the only sign. Vomiting occurs in a smaller
proportion of cases and is not usually a prominent feature.
Infection with FECV rarely causes disease of suﬃcient sever-
ity to require speciﬁc diagnosis of the underlying aetiological
agent.Theviruscanbedemonstratedinthefaecesofinfected
kittens by electron-microscopic examination or by reverse
transcriptase polymerase chain reaction (RT-PCR) assay.
However many healthy cats and kittens will also shed FCoV
in their faeces. Thus, other than for detection of carriers or
demonstrating the presence of FCoV infection in a colony of
cats, such investigations have limited value [15, 27].
FIPV variants of FCoV cause fatal peritonitis. Cats
with a poor cell-mediated immune response develop the
eﬀusive or “wet” form of disease, which is an immune
complex vasculitis that causes leakage of protein-rich ﬂuid
from the blood vessels into the abdominal cavity, leading
to a distended abdomen. In cats with partial cell-mediated
immunity, the non-eﬀusive or “dry” form develops, with
pyogranulomatous or granulomatous lesions in multiple
tissues. Dry FIP may become eﬀusive in the terminal stages
of the disease, when the immune system collapses [28, 29].
Ante-mortemdiagnosisofFIPisdiﬃcultandfrustrating.
Diﬃculties in deﬁnitively diagnosing FIP arise from the
lack of speciﬁc clinical signs, the lack of pathognomonic
biochemical abnormalities, and the low sensitivity and
speciﬁcity of tests routinely used in practice. FIP diagnosis is
based on assimilation of the history, haematology, and other
supportive diagnostic tests, including serology and ﬁndings
from imaging, tissue biopsies, and PCR [8, 15]. A typical
history of FIP cases includes acquisition of the cat from
a cattery and a fever that waxes and wanes and does not
Figure 1: Peritoneal cavity of a cat with eﬀusive FIP. A considerable
amount of ascitic ﬂuid can be seen in the abdominal cavity.
Figure 2: Intestines of a cat with eﬀusive FIP. Pyogranulomatous




maternally derived antibodies wane, mostly through contact
with faeces from their mothers or other FCoV-excreting cats
[27].
FIP is a disease with extremely diverse clinical manifes-
tations. In the “wet” form, the most characteristic sign is
a considerable amount of intracavitary eﬀusion (Figure 1).
The typical lesions of eﬀusive FIP are pyogranuloma and
ﬁbrinousplaquesontheserosalsurfacesofabdominalorgans
(Figures 2 and 3). Dyspnea, mild pyrexia, and muﬄed heart
sounds are common. Ocular involvement in FIP can include
uveitis, keratic precipitations, and changes in the coloration
of the iris. In the non-eﬀusive form, lesions commonly occur
in eyes and CNS, but granulomas may also be found in the
peritoneal cavity, leading to more diverse, and often more
vague, clinical signs [15, 29]( Figure 4).Veterinary Medicine International 3
Figure 3:PleuralcavityofacatwitheﬀusiveFIP.Fibrinousserositis
and adhesions of the lung with ﬁbrin strands can be seen.
Radiographs can reveal pleural, pericardial, or peritoneal
eﬀusion and hepatomegaly or renomegaly. Mesenteric lym-
phadenopathy may result in abdominal mass lesions in
some cats. Ultrasonography can be used to conﬁrm the
presence of abdominal ﬂuid in cats with minimal ﬂuid
volumes and to evaluate the pancreas, liver, lymph nodes
and kidneys. Magnetic resonance imaging (MRI) can reveal
periventricular contrast enhancement, ventricular dilation,
and hydrocephalus in cats with neurological FIP [30, 31].
3. GeneralDiagnostic Tests
There are a number of laboratory ﬁndings that are common
in cats with FIP, but none of them is pathognomonic.
Although it is often stated that lymphopaenia and neu-
trophilia are typical of FIP, this change can be interpreted
as a typical “stress leukogram” that occurs in many severe
systemic diseases in cats [32, 33].
The most consistent laboratory ﬁnding in FIP is an
increase in total serum protein concentration. This is found
in approximately 50% of cats with eﬀusive disease and 70%
of cats without eﬀusive disease. The increase in total protein
is caused by an increased concentration of globulins, mainly
γ-globulins. A γ-globulin concentration of more than 32% is
characteristic of FIP [33–36]. Changes in the serum protein
proﬁle lead to a decreased albumin-to-globulin (A:G) ratio.
An A:G ratio of less than 0.5 is strongly correlated with FIP
[37].
Acute phase proteins (APPs) are a large and varied
group of glycoproteins in the serum, concentrations of
which increase (or decrease) during certain inﬂammatory
disorders. The concentrations of APPs such as feline α1-
acid glycoprotein (fAGP) and serum amyloid A (SAA) can
be measured and facilitate the diagnosis. SAA and fAGP
concentrations increase in FIP, but they are not speciﬁc for
this disease. While moderately elevated levels of acute-phase
proteins are found in several inﬂammatory conditions, high
levels of fAGP (>1.5g/L) and SAA in plasma or eﬀusions can
indicate FIP and may be useful supportive tests [38–41].
Sampling from eﬀusions is an important diagnostic
step for FIP because tests on eﬀusions have much higher
diagnostic value than tests performed on blood samples.
Eﬀusions are typically clear yellow and viscous and may
form ﬁbrin strands. However, the presence of this type of
ﬂuid in body cavities alone is not diagnostic. Involvement of
peritoneal and plural cavities has been reported in 58% and
11% of FIP cases, respectively [7, 15].
The eﬀusion seen in FIP is classiﬁed as a modiﬁed
transudate to exudate with a very high-protein content
(>3.5g/dL) and moderate cellular content. FIP eﬀusions can
be examined using a simple and cheap method called the
Rivalta test. Adding a small drop of eﬀu s i o nt oat e s tt u b e
containing distilled water and a drop of 8% acetic acid can
cause precipitation because of the high-protein content. This
test seems to be useful for diﬀerentiation between eﬀusions
caused by FIP and eﬀusions caused by other diseases.
However, false-negative results can be obtained in cats with
bacterial peritonitis and false-positive results in cats with
lymphoma [37, 38].
Cytological evaluation of the eﬀusion in cats with FIP
reveals macrophages and neutrophils in a dense proteina-
ceous background. Neutrophils are non-degenerate or may
show mild nuclear degenerative changes. Lymphocytes and
plasma cells may also be found in the ﬂuid.
In a study by Hartmann and colleagues [37],
immunoﬂuorescent staining of intracellular FCoV antigen in
macrophages in eﬀusions had a positive predictive value of
100%, but the negative predictive value was not high (57%).
This could be due to the small numbers of macrophages in
the smear or masking of the antigen by competitive binding
of anti-FCoV antibodies in the eﬀusion [15].
Other laboratory parameters (e.g., liver enzymes, biliru-
bin, urea, and creatinine) can be variably increased, depend-
ing on the degree and localization of organ damage, but
they are not helpful in making an aetiological diagnosis
[15, 27, 38].
4.Serology
Measurements of antibody in serum are useful diagnostic
tools for detection of FCoV infection. However, since a large
percentage of healthy cats have antibodies against FCoV,
antibody testing is more helpful in the management of FCoV
infection (e.g., creating an FCoV-free cattery) [15]. The sen-
sitivity and speciﬁcity of a commercially available in-practice
test kit for detection of FCoV antibodies (ImmunoComb
FCoV Antibody Test Kit, Biogal, Israel) were 95% and 83%,
respectively [42].
AntibodytestingincatssuspectedtohaveFIPhaslimited




and render them unavailable to antigen in the test or because
the antibodies are lost in eﬀusions [15]. The use of anti-7b4 Veterinary Medicine International
(a) (b)
Figure 4: Kidney of a cat with non-eﬀusive FIP. Granulomatous lesions can be seen on the capsular surface and in the parenchyma of the
kidney.
(a) (b)
Figure 5: Granulomatous colitis of a cat with eﬀusive FIP showing inﬁltration of inﬂammatory cells.
proteins for serology does not appear to oﬀer any signiﬁcant
advantage [43].
Since FIP is an immune-mediated disease, antibody-
antigen complexes may circulate in the serum and eﬀu-
sions. The circulating complexes can be detected using a
competitive enzyme-linked immunosorbent assay (ELISA).
However, the utility of this assay is limited because the
positive predictive value of the test is not high (67%) and
there are many false-positive results [37, 44].
5.Reverse TranscriptasePolymerase
ChainReaction (RT-PCR)Assays
There are several reports of detection of FCoV by RT-PCR.
Some used primers targeted at conserved regions of the viral
genome, such as the Pol [45–47], the 7b gene [43, 48, 49],
and the 3
 untranslated region (3
 UTR) [50–52]. RT-PCR
assays using these primers are able to detect most, if not all,
FCoV strains and could be a valuable tool for screening for
the virus in cat populations. The sensitivity and speciﬁcity of
theRT-PCRassaycouldbeincreasedusingreal-timeRT-PCR
techniques[53].AsthesequenceoftheSgenediﬀersbetween
serotypes I and II, some RT-PCR assays have targeted the S
gene to diﬀerentiate the FCoV serotypes [18, 54].
Since speciﬁc genetic determinants of FCoV biotypes are
unknown and the genome contains various single nucleotide
polymorphisms (SNPs) [7, 55, 56], it is not possible to
design PCR primers to distinguish between FIPV and FECV
[11] and thus discriminate between FIP cases and FCoV-
positive healthy cats. In 2005, Simons and colleagues [57]
introduced a new PCR-based approach for detection of FIP.
The approach was based on the key pathogenic event in
FIP, viral replication in macrophages and monocytes. The
primers targeted the conserved region of the M gene and the
leader sequence to detect replicating virus in the blood. The
assayhadhighsensitivity andspeciﬁcity[57]andis currently
used in some diagnostic laboratories [28, 58]. However,
in a study on 26 cats, Can-S ¸ahna et al. (2007) found the
speciﬁcity of the assay using same primers to be poor [59].
The reason for the high-false-positive rate in healthy cats
(53%) in this second study is not clear, but the diﬀerent RNA
extraction kits used in these studies may have aﬀected the
quality of the template RNA and the RT-PCR outcome [47].Veterinary Medicine International 5
Figure 6: Kidney of a cat with FIP. Severe degenerative and
advanced necrotic changes within the lining endothelium of the
convoluted tubules (mostly cytoplasmolysis). Frank patchy intersti-
tial nephritis, as indicated by the heavy inﬁltration of lymphocytes,
plasma cells and some dead neutrophils, together with dilatation
and congestion of the interstitial blood vessels. The photograph was
kindly provided by Dr. Diane Addie.
Moreover, since both studies used conventional RT-PCR
techniques, they were not able to quantify the replicating
mRNA in blood of infected cats. Therefore, a quantitative
real-time RT-PCR assay that could determine the amount
o fv i r a lm R N Ai nb l o o dm a yb ea b l et ob e t t e rd i ﬀerentiate
FCoV-positive healthy cats from FIP cases.
RT-PCR assays have been used to detect FCoV in faecal
samples and are sensitive and useful for documenting that
a cat is shedding FCoV in faeces. Faecal samples must be
carefully handled, kept frozen, and protected from the RNA-
degrading enzymes that are present in most environments.
RT-PCR should be performed as soon as possible after
sampling, and even freezing samples may result in false
negative results. The strength of the RT-PCR signal in
faeces correlates with the amount of virus present in the
intestine [15]. Comparisons between RNA samples extracted
from faecal suspensions and FCoV-infected cell culture
supernatants showed that the presence of faecal factors
signiﬁcantlyinhibitedthereversetranscriptionreaction[47].
However, Pedersen et al. [26], found no evidence for faecal
inhibitors in their RT-PCR assay.
The virus can be detected in various tissues and ascitic
ﬂuid [50, 56, 60, 61]. Liver (48%) and spleen (42.3%)
samples appear more likely to contain detectable FCoV than
the kidneys (21.1%). In addition, the amounts of RNA
extracted from fresh tissues were signiﬁcantly higher than
from tissue ﬁxed in formalin, ethanol or Bouin’s solution
[61].
Primers designed to detect FIP in ill cats were also found
to be able to amplify FCoV in healthy cats [12, 37, 50]. Thus,
RT-PCR results should be interpreted in conjunction with
the clinical status of the cat and cannot be used as the sole
test to diagnose FIP. There are several plausible explanations
for false-negative RT-PCR results, including degradation
of RNA, failure of the reverse transcription reaction, and
variation in the nucleotide sequences of FCoVs. Infection
with CCV or TGEV could also contribute to false-positive
results because they share similar conserved regions [8, 54].
6. Histopathology andImmunohistochemistry
Histopathological conﬁrmation of FIP has been used to
deﬁne cases and has been regarded as the “gold standard”
for diagnostic test comparisons. Haematoxylin and eosin (H
& E) stained sections typically have localized inﬂammation
with macrophages, neutrophils, lymphocytes, and plasma
cells (Figure 5). Vascular lesions may be found surrounded
by proliferation of inﬂammatory cells and this is charac-
teristic for wet FIP. Pyogranulomas are mainly associated
with ﬁbrinous necrosis and may be large and consolidated or
numerous and small. Focal accumulations of inﬂammatory
cells and necrotic-proliferative lesions are typical of the
granulomatous lesions of dry FIP [18, 27, 58, 62]( Figure 6).
Immunohistochemical tests, such as immunoperoxidase
staining, may enable the detection of FCoV antigen in
tissue. Immunostaining cannot diﬀerentiate between FECV
and FIPV, but as FIPV replicates more actively, higher
concentrations of the viral antigen are found in FIP cases
[15]. Viral antigen concentrations are lower in lesions in cats
with dry FIP than in those of cats with wet FIP [14].
7. Conclusion
There are no pathognomonic clinical signs or speciﬁc
laboratory tests for FIP in cats. The presence of antibodies
does not indicate FIP and the absence of antibodies does
not exclude it. Many authors agree that serological data
alone have limited diagnostic value. PCR assays are able to
directly detect the FCoV genome but, although they appear
to be more sensitive for detection of coronaviral infection
in cats, the results must be interpreted in conjunction
with other clinical ﬁndings and cannot be used as the
sole criterion for diagnosis of FIP. A deﬁnitive diagnosis
of FIP should be conﬁrmed by histopathology or detection
of intracellular FCoV antigen by immunoﬂuorescent or
immunohistochemical staining.
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